FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
Atossa Genetics (NASDAQ: ATOS) reported Q3 EPS of ($0.15), versus ($0.13) reported last year. Revenue for the quarter came in at $772.2 thousand, versus $3.4 thousand reported last year.
Announced today that the National Cancer Institute, Division of Cancer Prevention, has approved a Letter of... More

